Published: Jul 13, 2026
Written by Klarity Editorial Team
Published: Jul 13, 2026

If you’re a psychiatrist or PMHNP trying to figure out what you can legally prescribe—especially via telehealth—you’ve probably noticed that the rules are a moving target. Between DEA waivers, state scope-of-practice laws, and ever-changing telehealth regulations, it’s easy to feel like you’re navigating a minefield.
Let’s cut through the confusion. This guide breaks down what psychiatrists and psychiatric nurse practitioners can actually prescribe in 2026, how telehealth has changed the game, and what differs between provider types and states.
As a fully licensed physician (MD or DO), a psychiatrist has unrestricted prescribing authority in all 50 states. If you’re board-certified in psychiatry and hold an active medical license plus DEA registration, you can prescribe:
The only real limitations are practical: you should prescribe within your area of competence, follow standard-of-care guidelines, and comply with your state’s prescription monitoring program (PMP) requirements. Most states now require checking the PMP database before prescribing any Schedule II-IV controlled substance—a minor administrative step that’s become routine.
Here’s where things got interesting. Pre-COVID, the Ryan Haight Act required an in-person medical evaluation before a provider could prescribe controlled substances. For psychiatrists treating ADHD, anxiety, or opioid dependency, that meant patients had to show up for at least one office visit.
Then the pandemic hit, and the DEA temporarily waived the in-person exam requirement for controlled substance prescribing via telehealth. That waiver has been extended multiple times and remains in effect through December 31, 2025 (texasnp.org).
What this means for you in 2026: You can initiate ADHD stimulants, prescribe benzodiazepines, or start someone on buprenorphine entirely via video visit, without ever seeing them in person. The DEA has proposed permanent rules that may require some modifications (like limiting initial prescriptions to 30 days or requiring an in-person follow-up within a certain timeframe), but those haven’t been finalized yet (natlawreview.com).
Stay alert: The DEA could change course. Monitor their announcements and be prepared to adapt your practice. For now, though, the flexibility remains.
Federal law sets the floor, but states can add restrictions. A few key examples:
Texas: You can prescribe controlled substances via telehealth for psychiatric conditions, but there’s a carve-out—Texas prohibits teleprescribing of Schedule II opioids for chronic pain (www.cchpca.org). For mental health treatment (ADHD stimulants, anxiety meds), you’re fine. Just make sure your telemedicine encounter meets the standard of care—real-time audio-visual communication that allows proper assessment (www.cchpca.org).
Florida: Florida explicitly allows controlled substance prescribing via telehealth for psychiatric treatment (www.flsenate.gov). This is a big deal—Florida carved out mental health care from restrictions that apply to pain management. You can start a Florida patient on Adderall or Ativan via video without issue.
New York: NY recently finalized regulations aligning state law with federal telehealth allowances for controlled substances (www.nixonpeabody.com). Translation: as long as the DEA waiver is active, you can prescribe controlled meds via telehealth in New York. You’ll need to check the state’s PMP (I-STOP registry) and use electronic prescribing, but otherwise you’re good.
California: CA law requires a ‘good faith exam’ before prescribing, but that exam can be conducted via telehealth (natlawreview.com). California psychiatrists have been leveraging the federal waiver to prescribe stimulants and other controlled meds remotely. Just remember to enroll in CURES (California’s PMP) and check it before writing Schedule II-IV prescriptions.
Bottom line: Most states permit teleprescribing of psychiatric controlled substances if you meet the standard of care and comply with PMP requirements. The few exceptions (like Texas’s ban on tele-opioids for chronic pain) generally don’t affect psychiatric practice.
If you’re a psychiatric mental health nurse practitioner, your prescribing authority depends heavily on where you practice. Unlike psychiatrists, who have universal authority, PMHNPs operate under a patchwork of state-specific scope-of-practice laws.
In about 34 states (as of 2026), PMHNPs can practice and prescribe independently—no physician oversight required (www.nursepractitioneronline.com). These ‘Full Practice Authority’ (FPA) states allow you to:
Examples: Washington, Oregon, Arizona, New Mexico, Colorado, Minnesota, and as of recent years, Massachusetts, Kansas, Indiana, Louisiana, and Michigan (www.nursepractitioneronline.com).
In these states, your prescribing authority mirrors a psychiatrist’s—except you operate under nursing board oversight rather than a medical board.
Some states grant independence after an initial period of supervised practice:
New York: PMHNPs must practice under a written collaborative agreement with a physician for their first 3,600 hours (roughly 2 years). After that, you can practice independently—no written agreement, no chart reviews, just an informal ‘collaborative relationship’ with physicians for consultation (www.jdsupra.com). In effect, experienced NY PMHNPs have full authority.
California: AB 890 created a tiered system. After 3 years of experience, PMHNPs can become ‘103 NPs’ and practice in group settings without direct supervision (www.rn.ca.gov). Starting January 1, 2026, those experienced NPs can apply for ‘104 NP’ status and practice fully independently, even solo (www.rn.ca.gov). Until then, new grads need physician-supervised standardized procedures.
Illinois: PMHNPs must complete 4,000 supervised hours plus 250 hours of continuing education before applying for Full Practice Authority (www.nursepractitionerlicense.com). During the transition period, you need a written collaborative agreement with a physician, and technically your prescriptions are under the physician’s delegated authority.
In states like Texas, Florida, and Pennsylvania, PMHNPs cannot practice or prescribe independently—ever—unless the law changes.
Texas: PMHNPs must have a Prescriptive Authority Agreement with a physician to prescribe anything (www.bon.texas.gov). The agreement must outline your scope, include regular physician meetings (monthly for the first 3 years, then quarterly), and the physician can supervise no more than 7 NPs at once (capitol.texas.gov). Texas also generally prohibits NPs from prescribing Schedule II controlled substances in outpatient settings—meaning you typically can’t prescribe ADHD stimulants on your own (www.cchpca.org).
Florida: PMHNPs are excluded from Florida’s ‘autonomous APRN’ law, which only applies to primary care NPs (www.npschools.com). You must practice under a supervising physician’s protocol. However, if you qualify as a ‘psychiatric nurse’ (PMHNP with 2+ years of experience under a psychiatrist), you can prescribe psychotropic controlled substances for mental health treatment—with no 7-day Schedule II limit that applies to other NPs (www.flsenate.gov). That’s a meaningful carve-out, but you still need a collaborating psychiatrist.
Pennsylvania: All PMHNPs must maintain a collaborative agreement indefinitely (www.pacnp.org). You can prescribe Schedule II-V drugs if delegated, but Schedule II prescriptions are limited to 30-day supplies and require physician notification within 24 hours. The physician must also co-sign a percentage of your charts regularly.
If you’re a PMHNP:
The trend is clear: more states are moving toward NP independence. Over a dozen states have granted FPA since 2020 (www.nursepractitioneronline.com). If you’re in a restricted state, don’t be surprised if legislation changes in the next few years.
Understanding reimbursement is critical because it directly impacts your income—and whether a telehealth practice model makes financial sense.
Psychiatrists typically bill medication management visits using standard Evaluation & Management (E/M) codes:
If you’re doing therapy plus med management, you can add psychotherapy codes (like 90833 for 20 minutes of therapy) to the E/M visit for additional reimbursement.
Here’s the good news: Medicare and most private insurers now pay the same rate for telehealth psychiatric visits as in-person. During the pandemic, telehealth parity became the norm for behavioral health, and many states have made it permanent.
For example:
Medicare will continue covering telehealth for mental health services indefinitely (with a minor requirement for an annual in-person visit that’s currently paused).
Here’s where it gets tricky: Medicare reimburses PMHNPs at 85% of the physician fee schedule when billed under the NP’s own NPI (www.nursepractitioneronline.com). Many private insurers follow suit.
So if a psychiatrist gets $95 for a 99213 med check, a PMHNP would get about $81 for the same service. That 15% haircut affects practice revenue models, especially if you’re building a high-volume telehealth practice.
Some states have passed ‘equal reimbursement’ laws requiring insurers to pay NPs the same as physicians for identical services, but they’re still in the minority.
Commercial insurance typically pays more than Medicare—often 50-100% above Medicare rates in high-cost areas. A major insurer might pay $150-200 for a 25-minute follow-up that Medicare reimburses at $136.
The catch? You have to be in-network, which means credentialing, contract negotiations, and administrative overhead. Many psychiatrists opt out of insurance panels entirely and operate cash-pay or out-of-network, charging $150-300 per visit. The economics depend on your patient volume and local market.
Let’s talk about the elephant in the room: acquiring qualified psychiatric patients is expensive and time-consuming.
If you’re building a solo telehealth practice, here’s what you’re up against:
When you factor in staff time to handle and qualify leads, no-show rates from cold leads, and months of trial-and-error with campaigns that fail, the all-in cost to acquire a qualified psychiatric patient through DIY marketing is typically $200-500+.
That’s a gamble. You’re spending thousands upfront with uncertain results, and most providers—especially those starting out or scaling—don’t have the budget or risk tolerance for that.
Klarity Health uses a pay-per-appointment model that removes the financial risk entirely. Instead of spending $3,000-5,000/month on marketing with no guarantee of patients, you pay a standard listing fee only when a pre-qualified patient books an appointment with you.
Here’s why that matters:
Compare that to DIY marketing: instead of gambling $50,000/year on uncertain patient flow, you pay a predictable fee per booked appointment. That’s guaranteed ROI vs a slot machine.
For PMHNPs in restricted states who need a collaborating physician, Klarity also provides that infrastructure—removing another major pain point and cost.
Full transparency: DIY marketing can eventually be cost-effective IF you have the budget, expertise, and patience. A well-optimized SEO strategy or a dialed-in Google Ads campaign can generate patients at a lower per-acquisition cost once you’ve figured it out.
But that’s the key phrase: ‘once you’ve figured it out.’ Most providers burn through five figures before they crack the code—if they crack it at all. And even then, you’re still managing ongoing ad spend, staff time, and patient lead qualification.
For most psychiatrists and PMHNPs—especially those starting out, scaling up, or who’d rather spend time treating patients than tweaking landing pages—a platform that handles patient acquisition removes the risk entirely.
Can psychiatrists prescribe Adderall or other stimulants via telehealth?
Yes, as of 2026. The DEA’s temporary waiver allowing controlled substance prescribing via telehealth remains in effect through December 31, 2025, and is expected to continue (texasnp.org). You can initiate ADHD stimulants entirely via video visit in most states. Stay alert for DEA rule changes that could modify this.
Do PMHNPs have the same prescribing authority as psychiatrists?
It depends on the state. In Full Practice Authority states (about 34 states), PMHNPs can prescribe independently, including controlled substances. In restricted states like Texas, Florida, and Pennsylvania, PMHNPs must practice under physician supervision and may face limitations on prescribing Schedule II drugs.
How much does Medicare pay for psychiatric medication management?
Medicare pays approximately $95 for a 15-minute follow-up (99213) and $136 for a 25-minute visit (99214) in 2026 (therathink.com). Initial evaluations (90792) pay around $173. PMHNPs receive 85% of these rates when billing under their own NPI.
Do I need to check the prescription monitoring program before prescribing?
Yes, in most states. Nearly all states now require providers to check their state PMP database before prescribing Schedule II-IV controlled substances. This applies to both in-person and telehealth prescribing. It’s typically a quick online check—part of standard practice now.
Can I prescribe across state lines via telehealth?
Only if you’re licensed in the state where the patient is located at the time of the consultation. You must hold an active license in each state where you treat patients. The Interstate Medical Licensure Compact (IMLC) can expedite the process for getting licenses in member states (Texas, Pennsylvania, and Illinois are members; New York, Florida, and California are not).
What’s the best way to build a psychiatric telehealth practice without burning through my savings on marketing?
Join a platform that handles patient acquisition for you. Instead of spending thousands per month on SEO, Google Ads, and directories with uncertain results, platforms like Klarity Health use a pay-per-appointment model—you only pay when a qualified patient books with you. No upfront marketing spend, no wasted ad budget, and you get built-in telehealth infrastructure and billing support.
If you’re a psychiatrist or PMHNP looking to expand your practice without the risk and hassle of DIY marketing, Klarity Health offers a straightforward path: join our provider network, set your availability, and start seeing pre-qualified patients. You control your schedule. You only pay when patients book. And you get the infrastructure—telehealth platform, EHR, billing support—handled for you.
Explore Klarity Health’s provider network and see how we’re helping psychiatrists and PMHNPs build thriving telehealth practices with zero marketing risk.
| Source & URL | Type of Source | Published/Updated | Reliability |
|---|---|---|---|
| California Board of Registered Nursing – AB 890 FAQs (www.rn.ca.gov) | Official state regulatory board website | Updated Nov 2023 | High – Primary source on CA NP scope |
| Texas Board of Nursing – APRN Practice FAQ (www.bon.texas.gov) | Official state board FAQ | Revised 2021 | High – Primary for TX NP rules |
| Zivian Health ‘2026 NP-Physician Collaboration Roadmap’ (www.zivianhealth.com) | Industry/Compliance blog | Feb 16, 2026 | Medium – Detailed overview of collab laws |
| NursePractitionerLicense.com – Illinois NP limitations (www.nursepractitionerlicense.com) | Educational portal | Updated Feb 12, 2024 | Medium – Consolidates state law |
| JDSupra Law News – NY NP Independence Article (www.jdsupra.com) | Law firm article | April 13, 2022 | High – Cites NY Education Law changes |
| Florida Statutes Chapter 464 & 456 (www.flsenate.gov) | Official state statutes | 2024 compilation | High – Primary legal text |
| Pennsylvania Coalition of Nurse Practitioners (www.pacnp.org) | Professional association site | Updated 2022 | Medium – Accurate reflection of PA law |
| NursePractitionerOnline.com – Practice Authority 2026 (www.nursepractitioneronline.com) | Professional article | Last verified Feb 5, 2026 | Medium – Provides overall trends |
| Center for Connected Health Policy – Texas Laws (www.cchpca.org) | Non-profit policy org | Updated Jan 19, 2026 | High – Comprehensive telehealth law database |
| Nat’l Law Review – Telehealth Prescribing Update (natlawreview.com) | Legal news | Aug 15, 2025 | High – Timely analysis by healthcare attorneys |
| Nixon Peabody – NY telemedicine rule (www.nixonpeabody.com) | Law firm client alert | June 18, 2025 | High – Explains NYSDOH final rule |
| Texas Nurse Practitioners Assoc. (texasnp.org) | Professional association news | Oct 6, 2023 | High – Cites DEA announcements |
| TheraThink – Insurance Reimbursement Rates 2026 (therathink.com) | Industry blog (medical billing) | 2026 rates | Medium – Uses CMS data for Medicare rates |
| Healing Psychiatry Florida – Psychiatrist Shortage (www.healingpsychiatryflorida.com) | Healthcare blog | Jan 15, 2026 | Medium – Data-driven analysis quoting HRSA stats |
| Texas Capitol – SB 406 Analysis (capitol.texas.gov) | State legislative text | 2013 (accessed 2026) | High – Primary legal source for TX supervision rules |
Find the right provider for your needs — select your state to find expert care near you.